Go Pro

Syndax Pharmaceuticals (SNDX) Institutional Ownership

Syndax Pharmaceuticals logo
$17.60 -0.62 (-3.40%)
As of 04:00 PM Eastern

Institutional Ownership Changes (13F Filings) for Syndax Pharmaceuticals (NASDAQ:SNDX)

Number of
Institutional Buyers
(last 12 months)
129
Total
Institutional Inflows
(last 12 months)
$710.23M
Number of
Institutional Sellers
(last 12 months)
68
Total
Institutional Outflows
(last 12 months)
$184.63M
Get SNDX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Syndax Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

SNDX Institutional Buying and Selling by Quarter

Syndax Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
9/9/2026Tidal Investments LLC72,212$1.58M0.0%+10.5%0.081%
9/9/2026WINTON GROUP Ltd76,500$1.67M0.1%+642.7%0.086%
9/9/2026Engineers Gate Manager LP21,401$468K0.0%-44.3%0.024%
9/9/2026Integrated Wealth Concepts LLC3,351$73K0.0%N/A0.004%
9/9/2026Squarepoint Ops LLC370,317$8.10M0.0%+104.0%0.418%
9/8/2026Allworth Financial LP1,169$26K0.0%-30.7%0.001%
9/8/2026Arizona State Retirement System23,120$505K0.0%+2.9%0.026%
9/8/2026Nykredit A S3,279$72K0.0%N/A0.004%
9/2/2026Allianz Asset Management GmbH9,300$203K0.0%N/A0.010%
8/26/2026HighTower Advisors LLC39,355$860K0.0%+6.3%0.044%
8/25/2026VIRGINIA RETIREMENT SYSTEMS ET Al21,000$459K0.0%N/A0.024%
8/21/2026Pale Fire Capital SE125,550$2.75M0.1%-55.9%0.142%
8/21/2026Nykredit A S3,279$72K0.0%N/A0.004%
8/20/2026Headlands Technologies LLC56,227$1.23M0.1%+121.4%0.063%
8/20/2026Alyeska Investment Group L.P.308,507$6.74M0.0%N/A0.348%
8/20/2026Wedbush Securities Inc.12,705$278K0.0%+40.3%0.014%
8/19/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC161,323$3.53M0.0%+7.7%0.182%
8/19/2026Hsbc Holdings PLC20,539$457K0.0%-12.5%0.023%
8/19/2026Wellington Management Group LLP124,241$2.72M0.0%+0.5%0.140%
8/18/2026Palo Alto Investors LP864,986$18.91M0.0%N/A0.976%
8/17/2026Seven Fleet Capital Management LP77,930$1.65M0.3%N/A0.088%
8/17/2026Bank of America Corp DE4,045,094$88.43M0.0%N/A4.565%
8/15/2026Man Group plc213,703$4.67M0.0%N/A0.241%
8/15/2026Trails Edge Capital Partners LP1,110,000$24.26M0.0%N/A1.253%
8/15/2026Jupiter Topco LLC39,335$860K0.0%N/A0.044%
8/15/2026Elmind Capital LP1,855,000$40.55M0.0%N/A2.093%
8/14/2026Hsbc Holdings PLC20,539$457K0.0%N/A0.023%
8/14/2026Parkman Healthcare Partners LLC877,256$19.18M2.0%N/A0.990%
8/14/2026Legal & General Group Plc65,483$1.43M0.0%N/A0.074%
8/14/2026The Manufacturers Life Insurance Company44,305$969K0.0%N/A0.050%
8/14/2026Algert Global LLC1,051,465$22.99M0.3%+13.2%1.187%
8/13/2026Connor Clark & Lunn Investment Management Ltd.40,891$894K0.0%N/A0.046%
8/12/2026Ieq Capital LLC54,835$1.20M0.0%N/A0.062%
8/11/2026Allworth Financial LP1,169$26K0.0%N/A0.001%
8/11/2026E Fund Management Co. Ltd.13,788$301K0.0%N/A0.016%
8/7/2026BlackRock Inc.9,020,006$197.18M0.0%N/A10.179%
8/7/2026Pallas Capital Advisors LLC9,460$207K0.0%N/A0.011%
8/7/2026Deutsche Bank AG95,315$2.08M0.0%N/A0.108%
8/6/2026Bank of New York Mellon Corp1,040,079$22.74M0.0%N/A1.174%
8/6/2026GSA Capital Partners LLP62,775$1.37M0.1%N/A0.071%
First Look: Elon’s “Starphone” (Ad)

Rumors are swirling that Elon Musk is developing a new mobile device that could rival the iPhone. It's said to be thinner, longer-lasting on battery, and cheaper to produce, with the ability to work worldwide without relying on cell towers. Former Bloomberg reporter and SAC Capital trader Josh Baylin says the evidence is mounting. He notes the FCC recently gave Musk a green light connected to his mobile plans, adding fuel to speculation. Baylin previously called the smartphone boom in 2004 and predicted Apple would sell a billion phones when others expected a fraction of that.tc pixel

See the full evidence behind Elon Musk's rumored new device.
7/10/2026Tema ETFs LLC72,212$1.58M0.1%+23.8%0.081%
7/9/2026Hennion & Walsh Asset Management Inc.342,883$7.50M0.2%+59.6%0.387%
5/19/2026Bank of America Corp DE4,249,836$99.28M0.0%-9.8%4.796%
5/18/2026ADAR1 Capital Management LLC17,500$409K0.0%+45.8%0.020%
5/18/2026California State Teachers Retirement System103,009$2.41M0.0%+31.7%0.116%
5/18/2026Royal Bank of Canada23,381$546K0.0%-7.7%0.026%
5/18/2026Eversept Partners LP2,885,622$67.41M3.6%-12.9%3.257%
5/16/2026The Manufacturers Life Insurance Company39,904$932K0.0%+56.7%0.045%
5/16/2026Quantinno Capital Management LP22,576$527K0.0%+11.0%0.025%
5/16/2026SummitTX Capital L.P.66,340$1.55M0.0%+69.6%0.075%
5/16/2026Orbimed Advisors LLC962,300$22.48M0.4%N/A1.086%
5/15/2026Granahan Investment Management LLC306,321$7.16M0.3%-16.5%0.346%
5/14/2026Healthcare of Ontario Pension Plan Trust Fund331,665$7.75M0.0%+141.0%0.374%
5/14/2026Renaissance Technologies LLC498,200$11.64M0.0%-8.6%0.562%
5/14/2026Knott David M Jr422,000$9.86M5.8%+1.7%0.476%
5/14/2026Sei Investments Co.217,600$5.08M0.0%+36.3%0.246%
5/7/2026KBC Group NV3,062$72K0.0%-40.9%0.003%
5/6/2026Allspring Global Investments Holdings LLC19,564$467K0.0%+11.4%0.022%
5/5/2026Bank of New York Mellon Corp1,004,498$23.47M0.0%-8.2%1.139%
5/4/2026Bleakley Financial Group LLC12,488$292K0.0%N/A0.014%
5/1/2026Torray Investment Partners LLC104,868$2.45M0.4%+7.2%0.119%
4/30/2026Hsbc Holdings PLC23,461$556K0.0%+3.2%0.027%
4/23/2026Yelin Lapidot Holdings Management Ltd.96,297$2.25M0.5%-11.1%0.109%
4/16/2026SG Americas Securities LLC38,548$900K0.0%-70.2%0.044%
4/16/2026Diversified Trust Co13,660$319K0.0%+23.0%0.015%
3/20/2026Hsbc Holdings PLC22,731$482K0.0%-59.8%0.026%
2/19/2026Invesco Ltd.160,525$3.37M0.0%+20.6%0.185%
2/18/2026Mercer Global Advisors Inc. ADV17,805$374K0.0%N/A0.020%
2/18/2026XTX Topco Ltd18,476$388K0.0%-39.2%0.021%
2/18/2026Virtus Investment Advisers LLC33,549$705K0.2%+214.6%0.039%
2/18/2026Wellington Management Group LLP35,630$749K0.0%-6.8%0.041%
2/18/2026SummitTX Capital L.P.39,127$822K0.0%-61.1%0.045%
2/18/2026Twinbeech Capital LP52,900$1.11M0.1%+19.4%0.061%
2/18/2026Sphera Funds Management LTD.762,563$16.02M3.0%+96.7%0.877%
2/18/2026Quadrature Capital Ltd14,886$313K0.0%-54.0%0.017%
2/18/2026Man Group plc44,638$938K0.0%-74.5%0.051%
2/18/2026Inspire Investing LLC22,142$465K0.0%-23.2%0.025%
2/18/2026Ishara Investments LP100,000$2.10M2.4%N/A0.115%
2/18/2026Elmind Capital LP1,855,000$38.97M11.5%N/A2.134%
2/18/2026Engineers Gate Manager LP26,265$552K0.0%-85.4%0.030%
2/18/2026Eversept Partners LP3,314,408$69.64M3.5%-4.4%3.813%
2/18/2026Catalio Capital Management LP1,196,807$25.15M4.7%-25.9%1.377%
2/18/2026Clearline Capital LP43,413$912K0.0%+27.0%0.050%
2/18/2026Apis Capital Advisors LLC724,000$15.21M2.7%+13.5%0.833%
2/17/2026Guggenheim Capital LLC14,538$305K0.0%+19.7%0.017%
2/17/2026ADAR1 Capital Management LLC12,000$252K0.0%N/A0.014%
2/17/2026Schonfeld Strategic Advisors LLC13,100$275K0.0%-90.1%0.015%
2/17/2026AQR Capital Management LLC925,974$19.46M0.0%+65.9%1.065%
2/17/2026Cetera Investment Advisers23,116$486K0.0%N/A0.027%
2/17/2026Lazard Asset Management LLC14,140$297K0.0%N/A0.016%
First Look: Elon’s “Starphone” (Ad)

Rumors are swirling that Elon Musk is developing a new mobile device that could rival the iPhone. It's said to be thinner, longer-lasting on battery, and cheaper to produce, with the ability to work worldwide without relying on cell towers. Former Bloomberg reporter and SAC Capital trader Josh Baylin says the evidence is mounting. He notes the FCC recently gave Musk a green light connected to his mobile plans, adding fuel to speculation. Baylin previously called the smartphone boom in 2004 and predicted Apple would sell a billion phones when others expected a fraction of that.tc pixel

See the full evidence behind Elon Musk's rumored new device.
2/17/2026MPM Bioimpact LLC1,337,702$28.11M3.2%-2.8%1.539%
2/17/2026Trexquant Investment LP87,514$1.84M0.0%N/A0.101%
2/17/2026Jump Financial LLC163,915$3.44M0.0%+23.5%0.189%
2/17/2026Price T Rowe Associates Inc. MD94,829$1.99M0.0%+4.1%0.109%
2/17/2026Integral Health Asset Management LLC200,000$4.20M0.2%N/A0.230%
2/17/2026Russell Investments Group Ltd.89,639$1.88M0.0%+12.7%0.103%
2/17/2026Atom Investors LP141,666$2.98M0.2%N/A0.163%
2/17/2026Granahan Investment Management LLC366,793$7.71M0.3%-7.5%0.422%
2/17/2026State of Wisconsin Investment Board40,761$856K0.0%-19.0%0.047%
2/17/2026ExodusPoint Capital Management LP554,761$11.66M0.1%+665.6%0.638%


SNDX Institutional Ownership - Frequently Asked Questions

During the previous two years, 242 institutional investors and hedge funds held shares of Syndax Pharmaceuticals. The most heavily invested institutionals were BlackRock Inc. ($197.18M), Vanguard Group Inc. ($130.90M), Goldman Sachs Group Inc. ($119.66M), State Street Corp ($96.57M), Bank of America Corp DE ($88.43M), Eversept Partners LP ($67.41M), and Point72 Asset Management L.P. ($53.48M).Learn more on Syndax Pharmaceuticals' institutional investors.

Of the 205 institutional investors that purchased Syndax Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BlackRock Inc. ($9.02M), Bank of America Corp DE ($5.01M), Elmind Capital LP ($3.71M), Soleus Capital Management L.P. ($1.91M), Assenagon Asset Management S.A. ($1.64M), Eventide Asset Management LLC ($1.27M), and Vanguard Group Inc. ($1.20M).

Institutional investors have bought a total of 33,747,621 shares in the last 24 months. This purchase volume represents approximately $710.23M in transactions.

Of the 68 institutional investors that sold Syndax Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Assenagon Asset Management S.A. ($2.00M), Granahan Investment Management LLC ($685.07K), Bank of America Corp DE ($602.03K), Eversept Partners LP ($581.69K), Millennium Management LLC ($552.16K), Dimensional Fund Advisors LP ($459.34K), and Catalio Capital Management LP ($417.91K).

Institutional investors have sold a total of 9,754,118 shares in the last 24 months. This volume of shares sold represents approximately $184.63M in transactions.



Institutional ownership data for NASDAQ:SNDX is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 9/9/2026. New 13F filings are added each quarter as they're published.
From Our Partners